Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.62 +0.01 (+0.62%)
As of: Sep 30, 2026 · 12:21 PM EDT

Chemomab Therapeutics Ltd. (CMMB) Operating Income (2017 - 2019)

Updated

Chemomab Therapeutics' Operating Income came in at $3.9 million for Q3 2019, up 55.6% from $2.51 million a year earlier but down 12.3% from the prior quarter.

Analysis

Chemomab Therapeutics Ltd. (CMMB) Operating Income (2017 - 2019) Analysis & Trends

Over the trailing twelve months to Sep 30, 2019, Chemomab Therapeutics reported Operating Income of $16.75 million, up 40.2% year-over-year; for FY2018, it came in at -$13.04 million.

  • Going back by year, Operating Income was -$9.39 million in FY2017 and -$4.64 million in FY2016.
  • The five-year range for quarterly Operating Income is $1.88 million (Q4 2017) to $5.43 million (Q1 2019).
  • Year-over-year, Operating Income has increased for four consecutive quarters, with growth averaging 45.1% over the last four quarters.
  • Business Quant data shows CMMB's Operating Income at $4.44 million (Q2 2019), $5.43 million (Q1 2019) and $2.98 million (Q4 2018) in the three quarters before Q3 2019.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 3.90 Mn
Jun 30, 2019 4.44 Mn
Mar 31, 2019 5.43 Mn
Dec 31, 2018 2.98 Mn
Sep 30, 2018 2.51 Mn
Jun 30, 2018 4.16 Mn
Mar 31, 2018 3.40 Mn
Dec 31, 2017 1.88 Mn
API Access

Chemomab Therapeutics Ltd. Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=CMMB&period=max&api_key=YOUR_API_KEY